Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK13 | O15264 | 16/20 | 0.87 |
| ▸ | MAPK12 | P53778 | 16/20 | 0.87 |
| ▸ | MAPK11 | Q15759 | 16/20 | 0.87 |
| ▸ | MAPK14 | Q16539 | 16/20 | 0.87 |
| ▸ | GCGR | P47871 | 5/20 | 0.87 |
| ▸ | RAF1 | P04049 | 12/20 | 0.76 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.66 |
| ▸ | BRAF | P15056 | 4/20 | 0.65 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.65 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2647825 | 0.93 | MAPK13 (1.00) | MAPK13MAPK12MAPK11MAPK14GCGR | |
| SCHEMBL2650287 | 0.93 | MAPK13 (0.80) | MAPK13MAPK12MAPK11MAPK14GCGR | |
| SCHEMBL2650067 | 0.93 | MAPK13 (0.80) | MAPK13MAPK12MAPK11MAPK14GCGR | |
| SCHEMBL2647360 | 0.91 | MAPK13 (0.77) | MAPK13MAPK12MAPK11MAPK14GCGR | |
| SCHEMBL2647873 | 0.90 | MAPK13 (0.72) | MAPK13MAPK12MAPK11MAPK14GCGR | |
| SCHEMBL2647098 | 0.89 | MAPK14 (0.80) | MAPK13MAPK12MAPK11MAPK14GCGR | |
| SCHEMBL2647680 | 0.88 | MAPK14 (0.73) | MAPK13MAPK12MAPK11MAPK14GCGR | |
| SCHEMBL2649049 | 0.88 | MAPK14 (0.78) | MAPK13MAPK12MAPK11MAPK14GCGR | |
| SCHEMBL2648004 | 0.88 | MAPK14 (0.83) | MAPK13MAPK12MAPK11MAPK14GCGR | |
| SCHEMBL2650007 | 0.85 | MAPK14 (0.81) | MAPK13MAPK12MAPK11MAPK14GCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0959886-A4 | TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS | MERCK & CO INC (US) | 2001-05-02 | — | — | EP | claimed |
| EP-0959886-A1 | TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS | Merck & Co., Inc. (US) | 1999-12-01 | — | — | EP | claimed |
| US-5880139-A | TREATING DIABETES, OBESITY, HYPERTENSION, CACHEXIA | MERCK & CO., INC. (US) | 1999-03-09 | — | — | US | claimed |
| WO-1998022109-A1 | TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS | MERCK & CO., INC. (US) | 1998-05-28 | — | — | WO | claimed |
| EP-0959886-A4 | TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS | MERCK & CO INC (US) | 2001-05-02 | — | — | EP | disclosed |
| EP-0959886-A1 | TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS | Merck & Co., Inc. (US) | 1999-12-01 | — | — | EP | disclosed |
| US-5880139-A | TREATING DIABETES, OBESITY, HYPERTENSION, CACHEXIA | MERCK & CO., INC. (US) | 1999-03-09 | — | — | US | disclosed |
| WO-1998022109-A1 | TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS | MERCK & CO., INC. (US) | 1998-05-28 | — | — | WO | disclosed |